Revenue Breakdown
Composition ()
No data
Revenue Streams
Astrana Health Inc (ASTH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Medicare, accounting for 61.6% of total sales, equivalent to $403.11M. Other significant revenue streams include Medicaid and Commercial. Understanding this composition is critical for investors evaluating how ASTH navigates market cycles within the Healthcare Facilities & Services industry.
Profitability & Margins
Evaluating the bottom line, Astrana Health Inc maintains a gross margin of 8.53%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 3.51%, while the net margin is 0.11%. These profitability ratios, combined with a Return on Equity (ROE) of 1.29%, provide a clear picture of how effectively ASTH converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ASTH competes directly with industry leaders such as NRC and QIPT. With a market capitalization of $1.13B, it holds a leading position in the sector. When comparing efficiency, ASTH's gross margin of 8.53% stands against NRC's 57.82% and QIPT's 55.20%. Such benchmarking helps identify whether Astrana Health Inc is trading at a premium or discount relative to its financial performance.
